Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors
Clinical trial NCT05728541 · UNKNOWN
Trial details
- NCT number
- NCT05728541
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2026-02-01
- Enrollment
- 367
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.